Scholarlink

Background <p>An urgent requirement necessitates maintenance of skeletal muscle health and physical performance during high altitude stress. Here, we deal with preclinical evaluation of a novel protective approach via supplementation of carnosine, an endogenous pleiotropic dipeptide. Protective efficacy of carnosine supplementation was investigated in hypobaric hypoxia (HH) exposed rat models. Further, safety study was also performed after prolonged oral administration of carnosine in rats.</p> Results <p>Oral supplementation with carnosine showed robust muscle protection at the dose of 50 mg/kg via increasing cross-sectional area (CSA) of myofibers. Co-supplementation of carnosine ameliorated HH induced muscle protein loss via decreasing calpain3, glucose regulating protein–78 (GRP-78) and myostatin activity and this was linked with increased Akt activity. Additionaly, carnosine also improved muscle strength via regulating energy metabolism (PGC-1α), myogenesis (Myo-G) and enhancing creatinine phosphokinase (CPK) activity. Further, safety efficacy of carnosine was also evaluated via administering different doses of carnosine for prolong period. The results suggested progressive increase in body weight, food intake, skeletal muscle weight and that was associated with enhance grip strength and myogenesis process. Interestingly, myostatin (a negative regulator of muscle mass) was declined in carnosine supplementated rats.</p> Conclusion <p>Carnosine showed no toxicity even when administered for long period. Ergo, mechanistic data depicted to ameliorate HH linked muscle protein loss at lower dose via influencing multiple deleterious pathways. Taken together, the results propose that endogenous pleiotropic dipeptide is a strong candidate for managing skeletal muscle health during high altitude stress condition.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Safety and efficacy investigation of carnosine, an endogenous dipeptide against hypobaric hypoxia induced muscle protein loss

  • 期刊论文

  • 发表日期：

    2025年5月10日

查看全文
  • Akshita Kumar,
  • Iti Garg,
  • Geetha Suryakumar,
  • Richa Rathor

摘要

Background

An urgent requirement necessitates maintenance of skeletal muscle health and physical performance during high altitude stress. Here, we deal with preclinical evaluation of a novel protective approach via supplementation of carnosine, an endogenous pleiotropic dipeptide. Protective efficacy of carnosine supplementation was investigated in hypobaric hypoxia (HH) exposed rat models. Further, safety study was also performed after prolonged oral administration of carnosine in rats.

Results

Oral supplementation with carnosine showed robust muscle protection at the dose of 50 mg/kg via increasing cross-sectional area (CSA) of myofibers. Co-supplementation of carnosine ameliorated HH induced muscle protein loss via decreasing calpain3, glucose regulating protein–78 (GRP-78) and myostatin activity and this was linked with increased Akt activity. Additionaly, carnosine also improved muscle strength via regulating energy metabolism (PGC-1α), myogenesis (Myo-G) and enhancing creatinine phosphokinase (CPK) activity. Further, safety efficacy of carnosine was also evaluated via administering different doses of carnosine for prolong period. The results suggested progressive increase in body weight, food intake, skeletal muscle weight and that was associated with enhance grip strength and myogenesis process. Interestingly, myostatin (a negative regulator of muscle mass) was declined in carnosine supplementated rats.

Conclusion

Carnosine showed no toxicity even when administered for long period. Ergo, mechanistic data depicted to ameliorate HH linked muscle protein loss at lower dose via influencing multiple deleterious pathways. Taken together, the results propose that endogenous pleiotropic dipeptide is a strong candidate for managing skeletal muscle health during high altitude stress condition.